Chris Viehbacher (born 1960) is a German-Canadian businessman. He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014. Viehbacher is currently Managing Partner of Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family.
Chris Viehbacher was born on March 26, 1960. He graduated from Queen's University in Kingston, Ontario, Canada. He is a certified public accountant, and he speaks French, German and English.
Viehbacher started his career at PriceWaterhouseCoopers. In 1988, he joined GlaxoSmithKline, where he worked for the next twenty years, including in France for ten years. Until October 29, 2014, he served as CEO of Sanofi and Chairman of Genzyme. Viehbacher has been Managing Partner of US-based healthcare investment fund Gurnet Point Capital since 2015.
Viehbacher was Chairman of the Pharmaceutical Research and Manufacturers of America from December 2010 to April 2012. He has been Chair of the CEO Roundtable on Cancer since February 2011. He is a member of The Business Roundtable and the International Business Council. He sits on the Board of Directors of Research America and the Burroughs Wellcome Fund. He will serve as President of the European Federation of Pharmaceutical Industries and Associations from June 2013 onwards.
In 2003, Viehbacher became a Knight in the Legion of Honour. In 2012, he received the Pasteur Foundation Award. He sits on the Board of Visitors of the Fuqua School of Business at Duke University.
Viehbacher is married and has three children, including a son.
- Christopher Viehbacher: Executive Profile & Biography - Businessweek
- Christopher Viehbacher - Forbes
- "Archived copy". Archived from the original on October 29, 2014. Retrieved October 29, 2014.CS1 maint: Archived copy as title (link) Sanofi
- Christopher A. Viehbacher | CEO Roundtable on Cancer
- "Ex-Sanofi CEO talks about his new $2 billion investment fund". Retrieved 2017-09-13.
- "Gurnet Point Capital nears deal to acquire drugmaker Innocoll: sources". Reuters. April 4, 2017. Retrieved 2017-09-13.
- "Subscribe to read". Financial Times. Retrieved 2017-11-17.
Gérard Le Fur
| CEO of Sanofi